Saperas Esteve, Dot Joan, Videla Sebastian, Alvarez-Castells Agustí, Perez-Lafuente Mercedes, Armengol Jose Ramón, Malagelada Juan-R
Digestive System Research Unit, University Hospital Vall d'Hebron, Barcelona, Spain.
Am J Gastroenterol. 2007 Apr;102(4):731-7. doi: 10.1111/j.1572-0241.2007.01058.x.
Capsule endoscopy (CE) is superior to push enteroscopy and small bowel barium radiography in detecting the source of obscure GI bleeding. We now compared whether CE has a superior diagnostic yield than CT angiography (CTA) or standard mesenteric angiography (ANGIO) in patients with obscure GI bleeding.
From June 2004 to October 2005, consecutive patients admitted for OGIB underwent both CTA and ANGIO, followed by CE, performed blindly by independent examiners within the next 7 days. The primary end point of the study was the diagnostic yield for each technique, defined as the frequency of detection of lesions with a high probability of bleeding.
Twenty-eight patients (16 men and 12 women, mean age 74 +/- 2 yr) with OGIB (overt bleeding in 20 cases and chronic occult in 8) were prospectively evaluated. CTA or standard angiography could be performed in 25 of 28 patients (applicability 86%), because of contrast allergy (1 patient) and chronic renal failure (2 patients). A source of bleeding was detected by CE in a greater proportion of patients, 72% (18 of 25, 95% CI 50.6-87.9%), than CTA, 24% (6 of 25, 95% CI 9.4-45.1%, P= 0.005 vs CE), or ANGIO, 56% (14 of 25, 95% CI 34.9-75.6%, P= NS). Similarly, CE was able to diagnose 100% of patients diagnosed by CTA and 86% of patients diagnosed by ANGIO. Moreover, CE was positive in 12 of 19 (63%) negative cases on CTA and in 6 of 11 (55%) negative cases on ANGIO. As a result of the CE findings, therapeutic intervention was undertaken in 9 of 19 (47%) patients with positive results.
CE detects more lesions than CTA or standard mesenteric angiography in patients with obscure GI bleeding and has a therapeutic impact in almost half of the patients with positive findings.
在检测不明原因胃肠道出血的来源方面,胶囊内镜(CE)优于推进式小肠镜和小肠钡剂造影。我们现在比较了在不明原因胃肠道出血患者中,CE的诊断率是否高于CT血管造影(CTA)或标准肠系膜血管造影(ANGIO)。
2004年6月至2005年10月,连续收治的不明原因胃肠道出血患者先接受CTA和ANGIO检查,随后在接下来7天内由独立检查者进行盲法CE检查。研究的主要终点是每种技术的诊断率,定义为检测到高度可疑出血病变的频率。
对28例不明原因胃肠道出血患者(16例男性,12例女性,平均年龄74±2岁,其中20例为显性出血,8例为慢性隐匿性出血)进行前瞻性评估。28例患者中有25例(适用率86%)可进行CTA或标准血管造影,原因是造影剂过敏(1例患者)和慢性肾衰竭(2例患者)。与CTA(24%,25例中的6例,95%可信区间9.4 - 45.1%,与CE相比P = 0.005)或ANGIO(56%,25例中的14例,95%可信区间34.9 - 75.6%,P = 无显著差异)相比,CE检测到出血来源的患者比例更高,为72%(25例中的18例,95%可信区间50.6 - 87.9%)。同样,CE能够诊断出CTA诊断患者中的100%以及ANGIO诊断患者中的86%。此外,在CTA检查阴性的19例患者中有12例(63%)CE检查呈阳性,在ANGIO检查阴性的11例患者中有6例(55%)CE检查呈阳性。由于CE检查结果,19例检查结果为阳性的患者中有9例(47%)接受了治疗干预。
在不明原因胃肠道出血患者中,CE检测到的病变比CTA或标准肠系膜血管造影更多,并且在近一半检查结果为阳性的患者中具有治疗影响。